Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,324,852 papers from all fields of science
Search
Sign In
Create Free Account
tavaborole
Known as:
5-Fluoro-2,1-benzoxaborol-1(3H)-ol
, 5-fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxaborole
A boron-containing small molecule antifungal agent with broad-spectrum activity against filamentous fungi, including both mold and yeast. 5-Fluoro-1…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
8 relations
Narrower (1)
AN2690
Broader (2)
Antifungal Agents
Bridged Bicyclo Compounds, Heterocyclic
Boron Compounds
Mycoses
Protein Synthesis Inhibitors [MoA]
tavaborole 43.5 MG/ML Topical Solution [Kerydin]
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Impact of direct-to-consumer drug advertising during the Super Bowl on drug utilization.
M. Gray
,
A. San-Juan-Rodriguez
,
N. Chen
,
C. Good
,
I. Hernandez
Research in Social and Administrative Pharmacy
2019
Corpus ID: 209446623
2019
2019
Novos Avanços no Tratamento da Onicomicose
C. G. Perusinha
,
C. Rosado
,
A. Lencastre
Journal of the Portuguese Society of Dermatology…
2019
Corpus ID: 209254372
O tratamento da micose do aparelho ungueal permanece um desafio nos dias de hoje. O foco infecioso encontra-se retido numa…
Expand
2016
2016
Evaluation of the Appearance of Nail Polish Following Daily Treatment of Ex Vivo Human Fingernails With Topical Solutions of Tavaborole or Efinaconazole.
T. Vlahovic
,
Dina J. Coronado
,
S. Chanda
,
Tejal Merchant
,
L. Zane
Journal of Drugs in Dermatology
2016
Corpus ID: 25209178
INTRODUCTION Patients with onychomycosis may mask infected nails with polish. Tavaborole topical solution, 5% is a boron-based…
Expand
2016
2016
Formulation of benzoxaborole drugs in PLLA: from materials preparation to in vitro release kinetics and cellular assays.
S. Sene
,
J. McLane
,
+5 authors
D. Laurencin
Journal of materials chemistry. B
2016
Corpus ID: 96853914
Benzoxaboroles are a family of organoboron molecules, which have been finding over the past few years an increasing number of…
Expand
2015
2015
In Vitro Nail Penetration of Tavaborole Topical Solution, 5%, Through Nail Polish on Ex Vivo Human Fingernails.
T. Vlahovic
,
Tejal Merchant MPharm
,
S. Chanda
,
L. Zane
,
Dina J. Coronado
Journal of Drugs in Dermatology
2015
Corpus ID: 46458682
BACKGROUND Onychomycosis is a common infection of the toenails that causes nail thickening and discoloration. The physical…
Expand
Review
2015
Review
2015
Onychomycosis: epidemiology, diagnosis, and treatment in a changing landscape.
T. Rosen
,
S. Friedlander
,
+4 authors
Aditya K. Gupta
Journal of Drugs in Dermatology
2015
Corpus ID: 26482304
Onychomycosis is an often overlooked and/or undertreated disease. This may be in part due to an under appreciation among both…
Expand
Review
2015
Review
2015
Tavaborole topical solution, 5% for the treatment of toenail onychomycosis.
L. Zane
,
Jacob J. Plattner
,
+4 authors
A. Gupta
Drugs of Today
2015
Corpus ID: 37209484
Tavaborole topical solution, 5% (tavaborole) is a novel, boron-based, antifungal pharmaceutical agent indicated for treatment of…
Expand
Review
2015
Review
2015
Tavaborole 5% Solution: A Novel Topical Treatment for Toenail Onychomycosis.
G. Gupta
,
K. Foley
,
A. Gupta
Skin therapy letter
2015
Corpus ID: 22858300
Onychomycosis is a stubborn fungal infection of the nails that can be difficult to effectively manage. One of the challenges with…
Expand
Review
2014
Review
2014
From the Test Tube to the Treatment Room: Fundamentals of Boron-containing Compounds and their Relevance to Dermatology.
J. D. Del Rosso
,
J. Plattner
˜The œJournal of clinical and aesthetic…
2014
Corpus ID: 43026763
The development of new drug classes and novel molecules that are brought to the marketplace has been a formidable challenge…
Expand
2010
2010
Post-transfer editing by a eukaryotic leucyl-tRNA synthetase resistant to the broad-spectrum drug AN2690.
Xiao-Long Zhou
,
M. Tan
,
Meng Wang
,
Xin Chen
,
E. Wang
Biochemical Journal
2010
Corpus ID: 25443467
Some aaRSs (aminoacyl-tRNA synthetases) develop editing mechanisms to correct mis-charged tRNA. The CP1 (connective peptide 1…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE